Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -170,033 | -43,476 | -116,484 | -81,199 | -49,858 |
| Depreciation Amortization | 880 | 443 | 1,646 | 1,149 | 795 |
| Accounts receivable | N/A | -1 | N/A | 42 | 182 |
| Accounts payable and accrued liabilities | 3,468 | 5,282 | N/A | -1,741 | -5,579 |
| Other Working Capital | 4,680 | 6,953 | -7,883 | -8,885 | -7,108 |
| Other Operating Activity | 88,256 | -1,303 | 1,140 | 2,708 | 5,880 |
| Operating Cash Flow | $-72,749 | $-32,102 | $-121,581 | $-87,926 | $-55,688 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -226 | -101 | -358 | -189 | -150 |
| Purchase Sale Intangibles | -408 | -375 | N/A | -1,765 | -1,757 |
| Other Investing Activity | -408 | -395 | -1,890 | -1,765 | -1,757 |
| Investing Cash Flow | $-634 | $-496 | $-2,248 | $-1,954 | $-1,907 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 62,896 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 244,213 | N/A | N/A | 101,614 | 74,838 |
| Common Stock Repurchased | N/A | N/A | N/A | -141 | N/A |
| Other Financing Activity | -554 | -278 | 100,512 | -832 | 26,093 |
| Financing Cash Flow | $306,555 | $-278 | $100,512 | $100,641 | $100,931 |
| Exchange Rate Effect | -130 | -100 | 61 | -51 | 13 |
| Beginning Cash Position | 115,551 | 115,551 | 138,807 | 138,807 | 138,807 |
| End Cash Position | 348,593 | 82,575 | 115,551 | 149,517 | 182,156 |
| Net Cash Flow | $233,042 | $-32,976 | $-23,256 | $10,710 | $43,349 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,749 | -32,102 | -121,581 | -87,926 | -55,688 |
| Capital Expenditure | -226 | -101 | N/A | -189 | -150 |
| Free Cash Flow | -72,975 | -32,203 | -121,581 | -88,115 | -55,838 |